|
|
OSUCCC
 |
Scott D. Jewell, Ph.D.
Assoc. Director for Biorepository and Biospecimen Resources
Research Assc Professor
College of Medicine
Pathology - Pathology
Innovation Center Room 2060
2001 Polaris Parkway Columbus,OH. 43240
|
Programs
|
 |
|
|
Current Publications
|
|
J Clin Oncol 27(11): 1814-21, 2009
|
|
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
|
|
Bertagnolli MM, Niedzwiecki D, Compton CC, Hahn HP, Hall M, Damas B, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Warren RS, Redston M
|
|
|
Clin Cancer Res 15(6): 2116-22, 2009
|
|
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
|
|
Bertagnolli MM, Warren RS, Niedzwiecki D, Mueller E, Compton CC, Redston M, Hall M, Hahn HP, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Loda M
|
|
|
J Mol Diagn 10(5): 415-23, 2008
|
|
Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling.
|
|
Szafranska AE, Davision TS, Shingara J, Doleshal M, Riggenbach JA, Morrison CD, Jewell S, Labourier E
|
|
|
J Clin Oncol 26(6): 848-55, 2008
|
|
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
|
|
Edelman MJ, Watson D, Wang X, Morrison C, Kratzke RA, Jewell S, Hodgson L, Mauer AM, Gajra A, Masters GA, Bedor M, Vokes EE, Green MJ
|
|
|
J Clin Oncol 26(34): 5638-44, 2008
|
|
Recommendations for collection and handling of specimens from group breast cancer clinical trials.
|
|
Leyland-Jones BR, Ambrosone CB, Bartlett J, Ellis MJ, Enos RA, Raji A, Pins MR, Zujewski JA, Hewitt SM, Forbes JF, Abramovitz M, Braga S, Cardoso F, Harbeck N, Denkert C, Jewell SD
|
|
|
